| Steel Magnolia Counseling Llc | |
|
202 W 10th St Bicknell IN 47512-1033 | |
| (812) 602-9723 | |
| (931) 240-0075 |
| Full Name | Steel Magnolia Counseling Llc |
|---|---|
| Speciality | Social Worker - Clinical |
| Location | 202 W 10th St, Bicknell, Indiana |
| Authorized Official Name and Position | Karla J Cox (OWNER) |
| Authorized Official Contact | 8126029723 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Steel Magnolia Counseling Llc Po Box 159 Bicknell IN 47512-0159 Ph: (812) 602-9723 | Steel Magnolia Counseling Llc 202 W 10th St Bicknell IN 47512-1033 Ph: (812) 602-9723 |
| NPI Number | 1992478283 |
|---|---|
| Provider Enumeration Date | 08/01/2021 |
| Last Update Date | 08/01/2021 |
| Certification Date | 07/27/2021 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992478283 | NPI | - | NPPES |
| 180.012398 | Other | IL | LICENSE |
| 39003076A | Other | IN | STATE LICENSE |
| 171357 | Other | KY | LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | (* (Not Available)) | Primary |
News Archive
The anti-inflammatory drug hydroxychloroquine should not be used to prevent infection in people who do not have covid-19, say a WHO Guideline Development Group (GDG) panel of international experts in The BMJ today.
Grip strength in the dominant hand and fat-free body mass (made mostly of muscle) increased when children with Duchenne muscular dystrophy (DMD) took the dietary supplement creatine at a dose of 0.1 grams per kilogram of body weight per day for four months.
Hoping to protect their children and grandchildren from a dismal economic future, concerned citizens across the country are prepared to make the difficult choices necessary to put government finances on a more responsible path.
A scientific "Renaissance man" whose work spans the fields of mathematics, linguistics, biotechnology and polymer physics, Erez Lieberman-Aiden, graduate student at the Harvard-MIT Division of Health Sciences and Technology, has been named the winner of the prestigious $30,000 Lemelson-MIT Student Prize. Lieberman-Aiden, one of four 2010 $30,000 Lemelson-MIT Collegiate Student Prize winners announced today, was selected for the breadth and depth of his innovations.
Thalidomide remains an enigma in the treatment of metastatic renal cell carcinoma (RCC). Initial clinical trials suggested a benefit, but more recently, subsequent randomized trials studying thalidomide in combination with other agents such as interferon have demonstrated no added benefit.
› Verified 9 days ago